Osteoartrosisde naproxen ve aspirin

dc.contributor.buuauthorYurtkuran, Merih
dc.contributor.buuauthorÖzcan, Orhan
dc.contributor.buuauthorKarakaya, Münir K.
dc.contributor.buuauthorNizamoğlu, Mine
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı.tr_TR
dc.date.accessioned2022-05-24T08:23:37Z
dc.date.available2022-05-24T08:23:37Z
dc.date.issued1984
dc.description.abstractOsteoartrosisin tedavisinde Naproxen (500 mg/gün) Aspirin (3 g/gün) ile karşılaştırıldı. Naproxen grubuna 17 hasta, Aspirin grubuna ise 15 hasta katıldı. Çalışmanın sonucunda; Naproxen klinik bulguların düzelmesinde Aspirinden daha etkili bulunmuştur.tr_TR
dc.description.abstractNaproxen (500 mg perday) has been compared with aspirin (3 g. perday) in the treatment of osteoarthrosis. 17 patient entered the Naproxen group and 15 the Aspirin group. As a result of this study; It had been found that Naproxen was more effective than Aspirin in decreasing clinical findings.en_US
dc.identifier.citationYurtkuran, M. vd. (1984). ''Osteoartrosisde naproxen ve aspirin''. Uludağ Üniversitesi Tıp Fakültesi Dergisi, 11(2-3), 275-279.tr_TR
dc.identifier.endpage279tr_TR
dc.identifier.issue2-3tr_TR
dc.identifier.startpage275tr_TR
dc.identifier.urihttp://hdl.handle.net/11452/26647
dc.identifier.volume11tr_TR
dc.language.isotrtr_TR
dc.publisherUludağ Üniversitesitr_TR
dc.relation.journalUludağ Üniversitesi Tıp Fakültesi Dergisitr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectOsteoartrosisde naproxenen_US
dc.subjectAspirinen_US
dc.subjectNaproxen in osteoarthrosisen_US
dc.titleOsteoartrosisde naproxen ve aspirintr_TR
dc.title.alternativeNaproxen and aspirin in osteoarthrosisen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
11_2-3_11.pdf
Size:
1.04 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: